Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kars M et al. - The incidence rates and the prevalence of dopamine agonist - treated hyperprolactinemia showed an overall preponderance in women, with a strong peak for women aged 25–34 years. In men no peak was found.

   

Related Articles

Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09    Relevance Score: 85%

Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09    Relevance Score: 80%

Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactin
Pediatric Rheumatology, 10/26/09    Relevance Score: 80%

Prolactinoma in Children and Adolescents
Hormone Research, 10/07/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address